カテゴリー： QYResearch, 世界

世界の多関節若年性特発性関節炎治療薬市場 2019年

【英語タイトル】Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Professional Survey Report 2019

・商品コード：DATA909X13266
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

※本調査レポートは、多関節若年性特発性関節炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他に、用途別には、病院、診療所、その他にセグメント区分し、多関節若年性特発性関節炎治療薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・多関節若年性特発性関節炎治療薬の世界市場概要
・多関節若年性特発性関節炎治療薬の製造コスト構成分析
・多関節若年性特発性関節炎治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・多関節若年性特発性関節炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・多関節若年性特発性関節炎治療薬のセグメント分析（種類別）
（エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）
・多関節若年性特発性関節炎治療薬のセグメント分析（用途別）
（病院、診療所、その他）
・多関節若年性特発性関節炎治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Biocon Ltd、Coherus BioSciences Inc、Livzon Pharmaceutical Group Inc、Momenta Pharmaceuticals Inc、Mycenax Biotech Inc、Oncobiologics Inc、Oncodesign SA、Panacea Biotec Ltd、Regeneron Pharmaceuticals Inc、Sandoz International GmbH、UCB SA、）
・多関節若年性特発性関節炎治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Polyarticular Juvenile Idiopathic Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polyarticular Juvenile Idiopathic Arthritis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Polyarticular Juvenile Idiopathic Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Polyarticular Juvenile Idiopathic Arthritis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Biocon Ltd
Coherus BioSciences Inc
Livzon Pharmaceutical Group Inc
Momenta Pharmaceuticals Inc
Mycenax Biotech Inc
Oncobiologics Inc
Oncodesign SA
Panacea Biotec Ltd
Regeneron Pharmaceuticals Inc
Sandoz International GmbH
UCB SA

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Etanercept Biosimilar
Tocilizumab Biosimilar
Sarilumab
Adalimumab Biosimilar
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Polyarticular Juvenile Idiopathic Arthritis Drug
1.1 Definition of Polyarticular Juvenile Idiopathic Arthritis Drug
1.2 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Type
1.2.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Etanercept Biosimilar
1.2.3 Tocilizumab Biosimilar
1.2.4 Sarilumab
1.2.5 Adalimumab Biosimilar
1.2.6 Others
1.3 Polyarticular Juvenile Idiopathic Arthritis Drug Segment by Applications
1.3.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Polyarticular Juvenile Idiopathic Arthritis Drug Overall Market
1.4.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (2014-2025)
1.4.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production (2014-2025)
1.4.3 North America Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)
1.4.4 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)
1.4.5 China Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)
1.4.6 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)
1.4.8 India Polyarticular Juvenile Idiopathic Arthritis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
2.3 Manufacturing Process Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
2.4 Industry Chain Structure of Polyarticular Juvenile Idiopathic Arthritis Drug

3 Development and Manufacturing Plants Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Polyarticular Juvenile Idiopathic Arthritis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Polyarticular Juvenile Idiopathic Arthritis Drug Production and Capacity Analysis
4.2 Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Analysis
4.3 Polyarticular Juvenile Idiopathic Arthritis Drug Price Analysis
4.4 Market Concentration Degree

5 Polyarticular Juvenile Idiopathic Arthritis Drug Regional Market Analysis
5.1 Polyarticular Juvenile Idiopathic Arthritis Drug Production by Regions
5.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production by Regions
5.1.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Regions
5.2 Polyarticular Juvenile Idiopathic Arthritis Drug Consumption by Regions
5.3 North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.3.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.3.2 North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export
5.4 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.4.1 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.4.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export
5.5 China Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.5.1 China Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.5.2 China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export
5.6 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.6.1 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.6.2 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export
5.7 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.7.1 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.7.2 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export
5.8 India Polyarticular Juvenile Idiopathic Arthritis Drug Market Analysis
5.8.1 India Polyarticular Juvenile Idiopathic Arthritis Drug Production
5.8.2 India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Polyarticular Juvenile Idiopathic Arthritis Drug Import and Export

6 Polyarticular Juvenile Idiopathic Arthritis Drug Segment Market Analysis (by Type)
6.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Production by Type
6.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Type
6.3 Polyarticular Juvenile Idiopathic Arthritis Drug Price by Type

7 Polyarticular Juvenile Idiopathic Arthritis Drug Segment Market Analysis (by Application)
7.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption by Application
7.2 Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Market Share by Application (2014-2019)

8 Polyarticular Juvenile Idiopathic Arthritis Drug Major Manufacturers Analysis
8.1 Biocon Ltd
8.1.1 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.1.2 Biocon Ltd Product Introduction, Application and Specification
8.1.3 Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Coherus BioSciences Inc
8.2.1 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.2.2 Coherus BioSciences Inc Product Introduction, Application and Specification
8.2.3 Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Livzon Pharmaceutical Group Inc
8.3.1 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.3.2 Livzon Pharmaceutical Group Inc Product Introduction, Application and Specification
8.3.3 Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Momenta Pharmaceuticals Inc
8.4.1 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.4.2 Momenta Pharmaceuticals Inc Product Introduction, Application and Specification
8.4.3 Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Mycenax Biotech Inc
8.5.1 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.5.2 Mycenax Biotech Inc Product Introduction, Application and Specification
8.5.3 Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Oncobiologics Inc
8.6.1 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.6.2 Oncobiologics Inc Product Introduction, Application and Specification
8.6.3 Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Oncodesign SA
8.7.1 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.7.2 Oncodesign SA Product Introduction, Application and Specification
8.7.3 Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Panacea Biotec Ltd
8.8.1 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.8.2 Panacea Biotec Ltd Product Introduction, Application and Specification
8.8.3 Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Regeneron Pharmaceuticals Inc
8.9.1 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.9.2 Regeneron Pharmaceuticals Inc Product Introduction, Application and Specification
8.9.3 Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Sandoz International GmbH
8.10.1 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
8.10.2 Sandoz International GmbH Product Introduction, Application and Specification
8.10.3 Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 UCB SA

9 Development Trend of Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug Market
9.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Trend Analysis
9.1.1 Global Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Polyarticular Juvenile Idiopathic Arthritis Drug Regional Market Trend
9.2.1 North America Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.2.2 Europe Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.2.3 China Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.2.4 Japan Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.2.5 Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.2.6 India Polyarticular Juvenile Idiopathic Arthritis Drug Forecast 2019-2025
9.3 Polyarticular Juvenile Idiopathic Arthritis Drug Market Trend (Product Type)
9.4 Polyarticular Juvenile Idiopathic Arthritis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Polyarticular Juvenile Idiopathic Arthritis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Polyarticular Juvenile Idiopathic Arthritis Drug
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Types in 2018
Figure Etanercept Biosimilar Product Picture
Figure Tocilizumab Biosimilar Product Picture
Figure Sarilumab Product Picture
Figure Adalimumab Biosimilar Product Picture
Figure Others Product Picture
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) (2014-2025)
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs) (2014-2025)
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Figure China Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Figure Japan Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Figure India Polyarticular Juvenile Idiopathic Arthritis Drug Market Size (Million USD) (2014-2025)
Table Polyarticular Juvenile Idiopathic Arthritis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug in 2018
Figure Manufacturing Process Analysis of Polyarticular Juvenile Idiopathic Arthritis Drug
Figure Industry Chain Structure of Polyarticular Juvenile Idiopathic Arthritis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Manufacturing Plants Distribution
Table Polyarticular Juvenile Idiopathic Arthritis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Polyarticular Juvenile Idiopathic Arthritis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Polyarticular Juvenile Idiopathic Arthritis Drug Production Share by Manufacturers in 2018
Table Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Share by Manufacturers in 2018
Table Polyarticular Juvenile Idiopathic Arthritis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Regions 2014-2019
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share by Regions in 2018
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions 2014-2019
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share by Regions in 2018
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Polyarticular Juvenile Idiopathic Arthritis Drug Consumption Market Share by Regions 2014-2019
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure China Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure India Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Polyarticular Juvenile Idiopathic Arthritis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Polyarticular Juvenile Idiopathic Arthritis Drug Market Share by Application (2014-2019)
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Biocon Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Coherus BioSciences Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Livzon Pharmaceutical Group Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Momenta Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Mycenax Biotech Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Oncobiologics Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Oncodesign SA Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Panacea Biotec Ltd Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Regeneron Pharmaceuticals Inc Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Product Introduction, Application and Specification
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate (2014-2019)
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Production Market Share (2014-2019)
Figure Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Market Share (2014-2019)
Table Sandoz International GmbH Polyarticular Juvenile Idiopathic Arthritis Drug Main Business and Markets Served
Table UCB SA Polyarticular Juvenile Idiopathic Arthritis Drug Production Sites and Area Served
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Polyarticular Juvenile Idiopathic Arthritis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Polyarticular Juvenile Idiopathic Arthritis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Polyarticular Juvenile Idiopathic Arthritis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Polyarticular Juvenile Idiopathic Arthritis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Polyarticular Juvenile Idiopathic Arthritis Drug by Application (2019-2025)
Table Polyarticular Juvenile Idiopathic Arthritis Drug Distributors List
Table Polyarticular Juvenile Idiopathic Arthritis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Biocon Ltd、Coherus BioSciences Inc、Livzon Pharmaceutical Group Inc、Momenta Pharmaceuticals Inc、Mycenax Biotech Inc、Oncobiologics Inc、Oncodesign SA、Panacea Biotec Ltd、Regeneron Pharmaceuticals Inc、Sandoz International GmbH、UCB SA、

★調査レポート[世界の多関節若年性特発性関節炎治療薬市場 2019年] (コード：DATA909X13266)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の多関節若年性特発性関節炎治療薬市場 2019年]についてメールでお問い合わせ

◆関連市場調査レポート◆

世界の全身性特発性若年性関節炎の治療市場 2019年
DATA909X16229 / QYResearch / 2019年11月20日 / ※本調査レポートは、全身性特発性若年性関節炎の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他に、用途別には、クリニック、病院、その他にセグメント区分し、全身性特発性若年性関節炎の治療の世界市場を分析しました。・エグゼクティブ・サマリー・全身性特発性若年性関節炎の治療の世界市場概要・全身性特発性若年性関節炎の治療の製造コスト構成分析・全身性特発性若年性関節炎の治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・全身性特発性若年性関節炎の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・全身性特発性若年性関節炎の治療のセグメント分析（種類別）（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）...The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Systemic Idiopathic Juvenile Arthritis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Idiopathic Juvenile Arthritis Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Systemic Idiopathic Juvenile Arthritis Treatment in North America, Europe, China, Japan, Southeast Asia and...

世界の特発性肺線維症薬市場 2019年
DATA909X09542 / QYResearch / 2019年11月20日 / ※本調査レポートは、特発性肺線維症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫抑制剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、特発性肺線維症薬の世界市場を分析しました。・エグゼクティブ・サマリー・特発性肺線維症薬の世界市場概要・特発性肺線維症薬の製造コスト構成分析・特発性肺線維症薬の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・特発性肺線維症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・特発性肺線維症薬のセグメント分析（種類別）（グルココルチコイド、免疫抑制剤、その他）...The global Idiopathic Pulmonary Fibrosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Idiopathic Pulmonary Fibrosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Idiopathic Pulmonary Fibrosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Idiopathic Pulmonary Fibrosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

世界の特発性低身長薬市場 2019年
DATA909X09543 / QYResearch / 2019年11月20日 / ※本調査レポートは、特発性低身長薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他に、用途別には、研究センター、病院、クリニックにセグメント区分し、特発性低身長薬の世界市場を分析しました。・エグゼクティブ・サマリー・特発性低身長薬の世界市場概要・特発性低身長薬の製造コスト構成分析・特発性低身長薬の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・特発性低身長薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・特発性低身長薬のセグメント分析（種類別）（BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他）...The global Idiopathic Short Stature Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Idiopathic Short Stature Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Idiopathic Short Stature Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Idiopathic Short Stature Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

世界の子供用製品市場 2019年
DATA909X10165 / QYResearch / 2019年11月20日 / ※本調査レポートは、子供用製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ベビーカー、チャイルドシート、ベビーキャリアに、用途別には、マタニティ及びチャイルドケアストア、ブランドストア、スーパーマーケット、オンラインにセグメント区分し、子供用製品の世界市場を分析しました。・エグゼクティブ・サマリー・子供用製品の世界市場概要・子供用製品の製造コスト構成分析・子供用製品の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・子供用製品の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・子供用製品のセグメント分析（種類別）（ベビーカー、チャイルドシート、ベビーキャリア）...The global Juvenile Product market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Juvenile Product volume and value at global level, regional level and company level. From a global perspective, this report represents overall Juvenile Product market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Juvenile Product in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Juvenile Product manufacturing...

特発性肺線維症治療の世界市場：規模・現状・予測2019-2025
DATA909X18557 / QYResearch / 2019年11月25日 / ※当調査レポートでは、特発性肺線維症治療の世界市場について調査・分析し、特発性肺線維症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、酸素療法、肺移植、その他）、用途別（病院、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。・レポートの概要・世界の特発性肺線維症治療市場動向・主要企業別マーケットシェア・特発性肺線維症治療の種類別市場規模2014-2019 （薬物クラス、酸素療法、肺移植、その他）・特発性肺線維症治療の用途別市場規模2014-2019 （病院、クリニック）・特発性肺線維症治療の北米市場：主要企業・種類別/用途別市場規模・特発性肺線維症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. In 2018, the global Idiopathic Pulmonary Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Idiopathic Pulmonary Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Idiopathic Pulmonary Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South...

世界の玩具＆子供向け製品市場 2019年
DATA909X16707 / QYResearch / 2019年11月22日 / ※本調査レポートは、玩具＆子供向け製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、0〜1年、2〜4年、5〜7年、>8年に、用途別には、家庭用、商業用にセグメント区分し、玩具＆子供向け製品の世界市場を分析しました。・エグゼクティブ・サマリー・玩具＆子供向け製品の世界市場概要・玩具＆子供向け製品の製造コスト構成分析・玩具＆子供向け製品の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・玩具＆子供向け製品の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・玩具＆子供向け製品のセグメント分析（種類別）（0〜1年、2〜4年、5〜7年、>8年）...The global Toys & Juvenile Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Toys & Juvenile Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Toys & Juvenile Products market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Toys & Juvenile Products in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

世界の若年性黄斑変性症治療市場 2019年
DATA909X10164 / QYResearch / 2019年11月20日 / ※本調査レポートは、若年性黄斑変性症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、若年性黄斑変性症治療の世界市場を分析しました。・エグゼクティブ・サマリー・若年性黄斑変性症治療の世界市場概要・若年性黄斑変性症治療の製造コスト構成分析・若年性黄斑変性症治療の開発・製造工場分析・主要メーカーの主な指標（生産能力、売上、価格分析）・若年性黄斑変性症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）・若年性黄斑変性症治療のセグメント分析（種類別）（アバンサカプタドペゴルナトリウム、エコチオパートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）...The global Juvenile Macular Degeneration Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Juvenile Macular Degeneration Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Juvenile Macular Degeneration Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Juvenile Macular Degeneration Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

◆H&Iグローバルリサーチのお客様（例）◆

世界の市場調査レポート

世界の多関節若年性特発性関節炎治療薬市場 2019年

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp